ArticleBMC medical informatics and decision making2026
Development and external validation of an interpretable machine learning model for predicting prolonged postoperative ICU length of stay in coronary artery bypass grafting patients using MIMIC-IV 3.1 and eICU-CRD 2.0.
Article in BMC medical informatics and decision making, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundProlonged postoperative intensive care unit (ICU) length of stay (LOS) after coronary artery bypass grafting (CABG) drives resource use yet remains difficult to anticipate at the 24-hour ICU evaluation moment when extended monitoring beyond 72 h is first considered. We developed and externally validated an interpretable machine-learning decision-support calculator for this deployment moment.
methodsAdult CABG patients were identified from MIMIC-IV 3.1 (n = 6,919; 7:3 stratified split for development) and eICU-CRD 2.0 (n = 5,972; external validation). The outcome was prolonged ICU LOS (> 3 days). Elastic Net plus Boruta selected eight bedside features collected within the first 24 h of ICU admission: 24-hour fluid intake, Charlson Comorbidity Index (CCI), Sequential Organ Failure Assessment (SOFA) score, Simplified Acute Physiology Score II (SAPS-II), Glasgow Coma Scale (GCS), vasopressor use, congestive heart failure, and atrial fibrillation. Nine machine-learning algorithms were compared by 10-fold cross-validation paired t-tests with Bonferroni and Benjamini-Hochberg correction. Calibration metrics included Hosmer-Lemeshow test, Integrated Calibration Index (ICI), expected-to-observed ratio, intercept, and slope (full Methods). SHapley Additive exPlanations (SHAP) provided per-patient feature attribution.
resultsCatBoost was selected as the deployed model. On the MIMIC-IV internal test set (n = 2,076), the area under the receiver-operating-characteristic curve (AUC) was 0.7739 (95% confidence interval 0.7379-0.8099), Hosmer-Lemeshow p = 0.224, calibration slope 0.973. On the eICU-CRD external cohort, AUC was 0.6452 (95% CI 0.6311-0.6602), calibration slope 0.998, ICI 0.023. At the prevalence-anchored threshold of 0.30, sensitivity was 0.55, specificity 0.65, positive predictive value 0.40, and negative predictive value 0.77. Decision Curve Analysis showed positive net benefit over treat-all and treat-none across t = 0.20-0.40. SHAP top-3 features were 24-hour fluid intake, CCI, and atrial fibrillation.
conclusionsThe model provides decision support at the post-CABG 24-hour ICU evaluation moment with modest discrimination and well-calibrated probabilities at deployment. The deployed online calculator renders per-patient feature contributions transparent at the bedside via SHAP; prospective validation is required before clinical deployment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.